Literature DB >> 11278395

Activated JNK phosphorylates the c-terminal domain of MLK2 that is required for MLK2-induced apoptosis.

D R Phelan1, G Price, Y F Liu, D S Dorow.   

Abstract

MAP kinase signaling pathways are important mediators of cellular responses to a wide variety of stimuli. Signals pass along these pathways via kinase cascades in which three protein kinases are sequentially phosphorylated and activated, initiating a range of cellular programs including cellular proliferation, immune and inflammatory responses, and apoptosis. One such cascade involves the mixed lineage kinase, MLK2, signaling through MAP kinase kinase 4 and/or MAP kinase kinase 7 to the SAPK/JNK, resulting in phosphorylation of transcription factors including the oncogene, c-jun. Recently we showed that MLK2 causes apoptosis in cultured neuronal cells and that this effect is dependent on activation of the JNK pathway (Liu, Y. F., Dorow, D. S., and Marshall, J. (2000) J. Biol. Chem. 275, 19035-19040). Furthermore, dominant-negative MLK2 blocked apoptosis induced by polyglutamine-expanded huntingtin protein, the product of the mutant Huntington's disease gene. Here we show that as well as activating the stress-signaling pathway, MLK2 is a target for phosphorylation by activated JNK. Phosphopeptide mapping of MLK2 proteins revealed that activated JNK2 phosphorylates multiple sites mainly within the noncatalytic C-terminal region of MLK2 including the C-terminal 100 amino acid peptide. In addition, MLK2 is phosphorylated in vivo within several of the same C-terminal peptides phosphorylated by JNK2 in vitro, and this phosphorylation is increased by cotransfection of JNK2 and treatment with the JNK activator, anisomycin. Cotransfection of dominant-negative JNK kinase inhibits phosphorylation of kinase-negative MLK2 by anisomycin-activated JNK. Furthermore, we show that the N-terminal region of MLK2 is sufficient to activate JNK but that removal of the C-terminal domain abrogates the apoptotic response. Taken together, these data indicate that the apoptotic activity of MLK2 is dependent on the C-terminal domain that is the main target for MLK2 phosphorylation by activated JNK.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11278395     DOI: 10.1074/jbc.M008237200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  Huntington's disease.

Authors:  S Davies; D B Ramsden
Journal:  Mol Pathol       Date:  2001-12

Review 2.  Differential vulnerability of neurons in Huntington's disease: the role of cell type-specific features.

Authors:  Ina Han; YiMei You; Jeffrey H Kordower; Scott T Brady; Gerardo A Morfini
Journal:  J Neurochem       Date:  2010-03-17       Impact factor: 5.372

3.  Regulation of mixed-lineage kinase activation in JNK-dependent morphogenesis.

Authors:  Rebecca A Garlena; Rebecca L Gonda; Alyssa B Green; Rachel M Pileggi; Beth Stronach
Journal:  J Cell Sci       Date:  2010-08-24       Impact factor: 5.285

4.  BRG1/BRM and prohibitin are required for growth suppression by estrogen antagonists.

Authors:  Sheng Wang; Baohua Zhang; Douglas V Faller
Journal:  EMBO J       Date:  2004-05-13       Impact factor: 11.598

5.  Stimulation of NeuroD activity by huntingtin and huntingtin-associated proteins HAP1 and MLK2.

Authors:  Edoardo Marcora; Katherine Gowan; Jacqueline E Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-24       Impact factor: 11.205

Review 6.  Mixed Lineage Kinase-c-Jun N-Terminal Kinase Axis: A Potential Therapeutic Target in Cancer.

Authors:  Ajay Rana; Basabi Rana; Rajakishore Mishra; Gautam Sondarva; Velusamy Rangasamy; Subhasis Das; Navin Viswakarma; Anumantha Kanthasamy
Journal:  Genes Cancer       Date:  2013-09

Review 7.  The functional contrariety of JNK.

Authors:  Ann M Bode; Zigang Dong
Journal:  Mol Carcinog       Date:  2007-08       Impact factor: 4.784

8.  Mixed lineage kinase phosphorylates transcription factor E47 and inhibits TrkB expression to link neuronal death and survival pathways.

Authors:  Neus Pedraza; Marta Rafel; Isis Navarro; Mario Encinas; Martí Aldea; Carme Gallego
Journal:  J Biol Chem       Date:  2009-09-28       Impact factor: 5.157

9.  Crosstalk and signaling switches in mitogen-activated protein kinase cascades.

Authors:  Dirk Fey; David R Croucher; Walter Kolch; Boris N Kholodenko
Journal:  Front Physiol       Date:  2012-09-18       Impact factor: 4.566

10.  A gain-of-function screen to identify genes that reduce lifespan in the adult of Drosophila melanogaster.

Authors:  Minoru Nakayama; Tomoki Ishibashi; Hiroyuki O Ishikawa; Hiroyasu Sato; Takao Usui; Takayuki Okuda; Hiroyuki Yashiro; Hironori Ishikawa; Yoshie Taikou; Asako Minami; Kengo Kato; Masataka Taki; Toshiro Aigaki; Wataru Gunji; Masaya Ohtsu; Yasufumi Murakami; Sei-Ichi Tanuma; Alice Tsuboi; Mai Adachi; Junpei Kuroda; Takeshi Sasamura; Tomoko Yamakawa; Kenji Matsuno
Journal:  BMC Genet       Date:  2014-04-16       Impact factor: 2.797

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.